X4 Pharmaceuticals (XFOR) Price-to-Earnings (P/E) Ratio
Price: $0.19
Market Cap: $33.00M
Avg Volume: 3.29M
Market Cap: $33.00M
Avg Volume: 3.29M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
X4 Pharmaceuticals's P/E ratios across different time periods:
- TTM: -1.02
- Annual: -3.94
- Quarterly: -0.93
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 6.66
- Price-to-Sales (P/S) Ratio: 57.68
Annual Ratios
X4 Pharmaceuticals Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-1.02
P/B Ratio (Annual)
6.66
P/S Ratio (Annual)
57.68
X4 Pharmaceuticals Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -3.94 | 6.66 | 57.68 |
| 2023 | -1.47 | 2.92 | 0.00 |
| 2022 | -0.67 | 0.85 | 0.00 |
| 2021 | -0.66 | 0.92 | 0.00 |
| 2020 | -2.08 | 1.77 | 43.03 |
| 2019 | -2.18 | 0.95 | 0.00 |
| 2018 | -0.15 | 0.30 | 1.83 |
| 2017 | -0.78 | 0.45 | 0.00 |
| 2016 | -3.40 | -1.38 | 0.00 |
| 2015 | -5.91 | -2.28 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for XFOR.